INTERFERON-ALPHA-2 (IFN) PLUS HYDROXYUREA FOR TREATMENT OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA

被引：4
|
作者：
SUTTORP, M
RISTER, M
SCHMITZ, N
机构：
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PEDIAT,W-2300 KIEL 1,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT INTERNAL MED 2,BONE MARROW TRANSPLANT UNIT,W-2300 KIEL 1,GERMANY
[3] KRANKENHAUS KEMPERHOF,DEPT PEDIAT,W-5400 KOBLENZ,GERMANY
[4] CHRISTIAN ALBRECHTS UNIV KIEL,CHILDRENS HOSP,CHWANENWEG 20,D-24105 KIEL,GERMANY
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 05期
关键词：
D O I：
10.1002/mpo.2950220513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [41] HYDROXYUREA THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA
    KENNEDY, BJ
    CANCER, 1972, 29 (04) : 1052 - +
  • [42] HYDROXYUREA IN THE THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA
    URABE, A
    MIZOGUCHI, H
    TAKAKU, F
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (08): : 1589 - 1593
  • [43] INTERFERON-ALPHA-2 IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS
    SEEWANN, HL
    GASTL, G
    LANG, A
    ABBREDERIS, K
    THALER, J
    FLENER, R
    HUBER, C
    BLUT, 1988, 56 (04): : 161 - 163
  • [44] MARROW IN CHRONIC MYELOID-LEUKEMIA PATIENTS - MORPHOFUNCTIONAL EFFECTS OF INTERFERON-ALPHA-2
    ABDULKADYROV, KM
    RUKAVITSYN, OA
    MOISEEV, SI
    RUGAL, VI
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1993, 38 (03): : 11 - 13
  • [45] Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia
    Thiele, J
    Kvasnicka, HM
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 855 - 862
  • [46] Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia
    Gale, RP
    Hehlmann, R
    Zhang, MJ
    Hasford, J
    Goldman, JM
    Heimpel, H
    Hochhaus, A
    Klein, JP
    Kolb, HJ
    McGlave, PB
    Passweg, JR
    Rowlings, PA
    Sobocinski, KA
    Horowitz, MM
    BLOOD, 1998, 91 (05) : 1810 - 1819
  • [47] AUTOIMMUNE-HEMOLYTIC ANEMIA (AIHA) UNDER INTERFERON-ALPHA-2 (IFN-ALPHA-2) THERAPY IN A PATIENT WITH CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
    HAAS, R
    DEBOBEN, A
    KIESEL, S
    KNAUF, W
    MARTIN, H
    HO, AD
    DORKEN, B
    HUNSTEIN, W
    BLUT, 1987, 55 (04): : 389 - 389
  • [48] Treatment of Ph+ chronic myelogenous leukemia (CML) with interferon alfa 2B R(IFN)
    Murro, H
    Bezares, R
    Longordo, F
    Fuchs, CR
    Saidon, G
    Diaz, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 813 - 813
  • [49] RECOMBINANT IFN-ALPHA-2 (RIFN-ALPHA-2) FOR TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BENIGN AND ACCELERATED PHASE
    GASTL, G
    AULITZKY, W
    TILG, H
    LUTTICHAU, I
    MICHLMAYR, G
    GADNER, H
    COSER, C
    SEEWANN, HL
    HUBER, H
    HUBER, C
    BLUT, 1987, 55 (04): : 387 - 387
  • [50] RECOMBINANT IFN-ALPHA-2 (RIFN-ALPHA-2) FOR TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BENIGN AND ACCELERATED PHASE
    GASTL, G
    AULITZKY, W
    TILG, H
    LUTTICHAU, I
    MICHLMAYR, G
    GADNER, H
    COSER, C
    SEEWANN, HL
    HUBER, H
    HUBER, C
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 737 - 737
12345